Corvus Pharmaceuticals Inc sell StockNews.com
Start price
28.09.24
/
50%
€4.55
Target price
28.09.25
-
Performance (%)
32.97%
End price
29.09.25
€6.05
Summary
This prediction ended on 29.09.25 with a price of €6.05. The price for Corvus Pharmaceuticals Inc massively increased, which is bad news for the SELL prediction by StockNews_com. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Corvus Pharmaceuticals Inc | -5.749% | -5.749% | -8.203% |
| iShares Core DAX® | 0.795% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -3.088% | -0.762% | 3.169% |
| iShares Nikkei 225® | -0.952% | -2.268% | 12.208% |
| iShares S&P 500 | -1.393% | 0.199% | 1.698% |
Comments by StockNews_com for this prediction
In the thread Corvus Pharmaceuticals Inc diskutieren
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for CRVS provided by MarketBeat
In the thread Trading Corvus Pharmaceuticals Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Corvus Pharmaceuticals Inc
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.92
03.04.23
03.04.23
-
03.04.24
03.04.24
81.96%
04.04.24
04.04.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.65
26.03.23
26.03.23
-
26.03.24
26.03.24
144.58%
27.03.24
27.03.24
Corvus Pharmaceuticals Inc
Start price
Target price
Perf. (%)
€0.68
18.03.23
18.03.23
-
18.03.24
18.03.24
157.58%
19.03.24
19.03.24